( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
2072.71
1210.57
1928.53
2221.64
Total Expenditure
2075.52
1261.96
2056.69
2218.9
PBIDT (Excl OI)
-2.80
-51.39
-128.16
2.73
Other Income
84.24
107.13
120.49
148.02
Operating Profit
81.42
55.74
-7.67
150.76
Exceptional Items
NA
NA
NA
NA
PBDT
74.10
46.57
-15.14
141.64
Depreciation
40.25
39.85
37.95
35.33
Profit Before Tax
33.85
6.72
-53.09
106.31
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-2.54
-24.26
-90.40
40.57
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-2.54
-24.26
-90.40
40.57
Minority Interest
NA
NA
NA
NA
Shares of Associates
-0.48
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-3.02
-24.26
-90.4
40.58
Equity Capital
222.78
222.78
222.78
222.78
Calculated EPS
-0.02
-0.21
-0.81
0.36
Calculated EPS (Annualised)
-0.10
-0.87
-3.24
1.45
No of Public Share Holdings
53282085
53282085
53282085
53282085
% of Public Share Holdings
47.84
47.84
47.84
47.84
PBIDTM% (Excl OI)
-0.13
-4.24
-6.64
0.12